The quality of reporting general safety parameters and...

The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors

Karimian, Zahra, Mavoungou, Sandra, Salem, Joe-Elie, Tubach, Florence, Dechartres, Agnès
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07518-5
Date:
December, 2020
File:
PDF, 1.51 MB
2020
Conversion to is in progress
Conversion to is failed